Wealthcare Advisory Partners’s Chimera Investment CIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-169
Closed -$5K – 490
2020
Q1
$5K Buy
169
+4
+2% +$227 ﹤0.01% 1092
2019
Q4
$10K Buy
165
+4
+2% +$244 ﹤0.01% 933
2019
Q3
$9K Buy
161
+4
+3% +$233 ﹤0.01% 938
2019
Q2
$9K Buy
157
+4
+3% +$227 ﹤0.01% 928
2019
Q1
$9K Buy
153
+4
+3% +$225 ﹤0.01% 834
2018
Q4
$8K Buy
149
+4
+3% +$219 ﹤0.01% 832
2018
Q3
$8K Buy
145
+4
+3% +$225 ﹤0.01% 890
2018
Q2
$8K Buy
141
+4
+3% +$216 ﹤0.01% 886
2018
Q1
$7K Buy
137
+4
+3% +$209 ﹤0.01% 786
2017
Q4
$7K Buy
133
+3
+2% +$168 ﹤0.01% 732
2017
Q3
$7K Buy
+130
New +$7.38K ﹤0.01% 595

Other funds holding CIM

Wealthcare Advisory Partners's CIM Position: Q2 2020 in Review

Wealthcare Advisory Partners sold out of Chimera Investment (CIM) in Q2 2020, closing a stake of 169 shares — an estimated $5K sold.

Wealthcare Advisory Partners first reported a position in CIM in Q3 2017 and held it in 11 quarters. The position peaked at $10K in Q4 2019. 269 funds tracked by Wall St. Rank hold CIM as of Q2 2020.

  • Wealthcare Advisory Partners reported no remaining Chimera Investment position as of Q2 2020 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 169 Chimera Investment shares in Q2 2020, an estimated $5K.
  • Wealthcare Advisory Partners first reported a position in Chimera Investment in Q3 2017 and held it in 11 quarters.
  • Wealthcare Advisory Partners's Chimera Investment position peaked at $10K in Q4 2019.
  • 269 funds tracked by Wall St. Rank held Chimera Investment as of Q2 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2020, filed 29 Jul 2020.